affidea-logo
    • Who we are
      • Locations
      • Our Core Belief
      • Affidea Ownership
      • Our Story
      • Ethics and Compliance
      • Affidea Commitment on ESG
    • Our Care Delivery Model
      • Clinical Excellence
        • Integrated Clinical Governance Model
        • Patient Safety
        • Dose Excellence
        • MRI Excellence
        • Research & Development
        • Presentations & Publications
      • Continuous Improvement
      • Innovative Medical and Digital Technology
      • Outstanding Patient Experience
      • Professional Development
        • Affidea Leadership Academy
        • Affidea Clinical Academy
        • Sub specialty groups
        • Affinity program
    • Media
      • News
      • Affidea in Society
      • Media Relations
      • Media Kit
    • What we do
      • Advanced Diagnostics
      • Primary Care
      • Coordinated Medical Care
      • Cancer Care
    • Join us
      • Opportunities
      • Meet Our People
    • Get in Contact
    • Find A Centre
    • Privacy Policy
    • Terms of Use
    • Webinars

News

Affidea
08.07.2022

AFFIDEA CONTINUES ITS STRATEGIC GROWTH JOURNEY, WITH ACQUISITIONS IN SPAIN, PORTUGAL AND ROMANIA

08.07
2022
Affidea
30.06.2022

Affidea wins “Diagnostic Provider of the Year at 2022 Health Investors Awards

30.06
2022
Affidea
30.06.2022

The First European School of Oncology (ESO) Visiting Professor Meeting in BiH with a Multi-disciplinary Approach Organised by Affidea Bosnia

30.06
2022